Furthermore, while BRAF inhibitors are effective in blocking growth of cancer cells driven by the BRAF-V600E mutation, BRAF inhibition paradoxically activates MAPK signaling in KRAS mutant tumors through inducing increased dimerization of BRAF with RAS (138). This evidence concerns the gene BRAF and cancer.